Appendix G to Exclusive Distribution and Licensing Agreement between Resdevco Ltd. and Wize Pharma Ltd. signed on May 1, 2015 dated July 20, 2017
Contract Categories:
Business Operations
- Distribution Agreements
EX-10.19 12 fs42017ex10-19_ophthalix.htm APPENDIX G. TO THE EXCLUSIVE DISTRIBUTION AND LICENSING AGREEMENT, DATED MAY 1, 2015
Exhibit 10.19
Appendix G. to the Exclusive Distribution and Licensing Agreement, dated May 1, 2015
July 20, 2017
Resdevco Ltd. hereby declares that all its patents and trade names related to the LO2A unit dose eye drops may be used by Wize Phanna Ltd./ Ocu Wize Ltd. in the territories to which the Exclusive Distribution and Licensing Agreement, dated May 1, 2015 is extended (at present Israel and the Ukraine) as long as the contract for those territories is valid
Sincerely,
| Wize Pharma Ltd. | Resdevco Ltd. | |||
| By: | /s/ Or Eisenberg | By: | /s/ Prof. S. Dikstein | |
| Name: | Or Eisenberg | Name: | Prof. S. Dikstein | |
| Title: | CFO & CEO | Title: | CEO | |
